Silverton, Natalie A.
Lofgren, Lars R.
Kuck, Kai
Stoddard, Gregory J.
Johnson, Russel
Ramezani, Ali
Hoareau, Guillaume L.
Funding for this research was provided by:
National Kidney Foundation of Utah and Idaho
University of Utah Department of Anesthesiology
International Anesthesia Research Society
National Institutes of Health (UM1TR004409)
U.S. Department of Defense (Award W81XWH-20-1-0180)
Article History
Received: 1 November 2023
Accepted: 10 January 2024
First Online: 1 February 2024
Competing interests
: Natalie Silverton, Kai Kuck, and Lars Lofgren are inventors on a patent application for a urine oxygen and flow sensing technology. This prototype is under development for commercial consideration by Natalie Silverton and Kai Kuck but as of yet no commercial activity has occurred. This technology is unrelated to near-infrared spectroscopy monitoring. Nonetheless, this work was performed under a conflict of interest management plan approved by the University of Utah Conflict of Interest Office. This included disclosure of conflict of interest to patients and collaborators and an independent peer review of the manuscript. Guillaume L. Hoareau is a consultant and shareholder of Certus Critical Care. The interpretation and reporting of these data are the responsibility of the authors alone and should not be seen as an official policy of or interpretation by the US Government, nor does this report necessarily represent the official views of the National Institutes of Health. No other authors have any disclosures to declare.